A New 2α,5α,10β,14β-Tetraacetoxy-4(20),11-Taxadiene (SIA) Derivative Overcomes Paclitaxel Resistance by Inhibiting MAPK Signaling and Increasing Paclitaxel Accumulation in Breast Cancer Cells

PLoS ONE - United States
doi 10.1371/journal.pone.0104317
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

BRCA1-IRIS Inactivation Overcomes Paclitaxel Resistance in Triple Negative Breast Cancers

Breast Cancer Research
Cancer ResearchOncology
2015English

Paclitaxel in Breast Cancer

Oncologist
Cancer ResearchMedicineOncology
1998English

Enriched Variations in TEKT4 and Breast Cancer Resistance to Paclitaxel

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2014English

Pristimerin Overcomes Adriamycin Resistance in Breast Cancer Cells Through Suppressing Akt Signaling

Oncology Letters
Cancer ResearchOncology
2016English

Different Administration Strategies With Paclitaxel Induce Distinct Phenotypes of Multidrug Resistance in Breast Cancer Cells

Cancer Letters
Cancer ResearchOncology
2013English

Sulforaphane Sensitizes Human Breast Cancer Cells to Paclitaxel‑induced Apoptosis by Downregulating the NF‑κB Signaling Pathway

Oncology Letters
Cancer ResearchOncology
2017English

Paclitaxel-Induced Apoptosis Is Blocked by Camptothecin in Human Breast and Pancreatic Cancer Cells

Oncology Reports
MedicineCancer ResearchOncology
2011English

Aurora Kinase a Stabilizes FOXM1 to Enhance Paclitaxel Resistance in Triple‐negative Breast Cancer

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2019English

Downregulation of miR‑200c‑3p Contributes to the Resistance of Breast Cancer Cells to Paclitaxel by Targeting SOX2

Oncology Reports
MedicineCancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy